Skip to main content
. 2023 Apr 27;15(5):1342. doi: 10.3390/pharmaceutics15051342

Table 2.

Relative number of acidic and basic variants after MFD and storage at the respective temperatures over the course of 6 months for all formulations.

Formulation Number Acidic Variants (%) Basic Variants (%)
0 m 6 m 0 m 6 m
4 °C 25 °C 40 °C 4 °C 25 °C 40 °C
F1 24.5 ± 0.6 26.9 ± 1.5 24.9 ± 1.6 25.7 ± 1.4 13.7 ± 0.3 14.6 ± 0.2 13.7 ± 1.0 15.5 ± 0.3
F2 25.8 ± 0.1 27.1 ± 1.4 26.1 ± 2.6 30.5 ± 1.6 13.1 ± 0.3 13.0 ± 0.6 13.4 ± 0.5 20.9 ± 0.7
F3 26.0 ± 0.1 25.5 ± 1.0 26.6 ± 0.6 28.3 ± 1.0 14.5 ± 0.3 13.2 ± 0.2 15.1 ± 0.5 20.5 ± 0.6
F4 24.3 ± 0.6 26.6 ± 2.2 26.3 ± 2.9 28.1 ± 2.4 11.0 ± 0.6 13.5 ± 0.4 14.2 ± 0.4 18.2 ± 1.4
F5 27.8 ± 0.1 29.8 ± 0.3 31.0 ± 0.5 32.9 ± 0.8 11.6 ± 0.6 13.5 ± 1.2 16.3 ± 0.5 25.7 ± 1.8
F6 27.2 ± 1.0 29.0 ± 1.1 31.2 ± 0.4 43.7 ± 0.2 11.8 ± 1.9 12.1 ± 0.4 16.4 ± 0.5 21.4 ± 0.3

The values are means (n = 3) ± standard deviation. m, month.